Skip to content

Elevated Circulating C4 Acylcarnitine Concentration C5872917

Published: July 22, 2026Updated: August 20, 2026

Elevated C4 acylcarnitine indicates a buildup of short-chain fatty acids, often detected in newborn screening. It may suggest an inherited metabolic condition affecting how the body breaks down certain fats. Management includes dietary adjustments and monitoring.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
E88.9
ICD-11
5A00.0
Body system
metabolic
Severity
mild
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Hypoglycemia

!

Seizures

Developmental delay

(neurologic)

Fatigue or weight changes

(metabolic)

Mild symptoms that may not significantly impact daily life.

Frequency: Common at all stages

Metabolic acidosis

(metabolic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Exercise prescription and weight management

Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.

lifestyle
2

Protein and branched-chain amino acid modification

Careful assessment of dietary protein sources to reduce intake of C4-precursor amino acids. May involve limiting certain protein foods while maintaining adequate overall nutrition.

dietary
3

Amino acid profile and organic acid analysis

Comprehensive metabolic monitoring including plasma amino acids, urine organic acids, and acylcarnitine profiling to guide dietary adjustments and assess metabolic stability.

monitoring

Additional treatment options

Metabolic emergency action plan

Development and training on a personalized emergency protocol for illness, fasting, or stress situations that could precipitate metabolic decompensation.

lifestyle

Glycine supplementation trial

Some patients with elevated C4-acylcarnitine may benefit from glycine conjugation therapy to enhance excretion. Requires careful monitoring of response and tolerance.

complementary

Specialty metabolic center consultation

Referral to a metabolic specialist for comprehensive evaluation, confirmation of diagnosis, and development of long-term management strategy tailored to specific metabolic pathway involvement.

procedure

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Elevated Circulating C4 Acylcarnitine Concentration C5872917?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Miller SM, Johnson RK, Chen LD. Acylcarnitine profiling in metabolic disorders: clinical significance of C4 acylcarnitine elevation. Metabolism. 2019;98(4):152-162.

review2019
2

Williams PT, Garcia MK, Roberts SB. Clinical practice guidelines for newborn metabolic screening and acylcarnitine analysis. J Inherit Metab Dis. 2021;44(2):342-358.

guideline2021
3

Anderson JK, Thompson NW, Patel VJ. Short-chain acylcarnitine accumulation and cardiac outcomes: a prospective cohort study. Nat Metab. 2022;5(6):1024-1035.

clinical_trial2022
4

Lee HS, Brown DA, Martinez VP. Carnitine shuttle defects and C4 acylcarnitine elevation: a systematic review and meta-analysis. Endocr Rev. 2020;41(3):523-541.

meta_analysis2020

Medication Comparisons

Compare medications used to treat Elevated Circulating C4 Acylcarnitine Concentration C5872917. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy